Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for a range of medical conditions.
Next stop is 5k
Note
During the upcoming year the company plans to complete the development work of neural human implants including QC methods and full QC release of the implants and implants raw materials: hydrogel and induced Pluripotent Stem Cells (iPSCs).
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.